newsfilter
← Latest News
GlobeNewswire·

Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2026

Company Announcement Net sales of DARZALEX® in the first quarter of 2026 totaled USD 3,964 millionGenmab receives royalties on worldwide net sales from Johnson & Johnson (J&J, legal entity Janssen Biotech,